Matching placebo to K-757 and matching placebo to K-833

DRUG2 trials

Sponsors

Kallyope Inc.

Conditions

Obesity

Phase 1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 in Healthy Overweight/Obese Volunteers

CompletedNCT05900531

Kallyope Inc.Obesity

Start: 2022-09-21End: 2023-05-31Updated: 2024-11-22

Phase 2

A Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833

CompletedNCT06019559

Kallyope Inc.Obesity

Start: 2023-09-15End: 2024-02-19Updated: 2025-02-26